Emmes publications: 1875+ publications

A key difference between Emmes and other CROs is Emmes’ prolific publishing
expertise, a total of 2300+, averaging 60 per year

Emmes staff members have prepared and published more than 2,300+ scientific publications and presentations, a reflection of our commitment to quality research. We have been even more prolific over the past three years, averaging more than 60 per year.

Featured Publications

The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children

Safety and Tolerability of Chikungunya Virus-Like Particle Vaccine in Healthy Adults: A Phase 1 Dose-Escalation Trial

Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand

Peripheral-Blood Stem Cells Versus Bone Marrow from Unrelated Donors

Safety and Immunogenicity of a Recombinant Nonglycosylated Erythrocyte Binding Antigen 175 Region II Malaria Vaccine in Healthy Adults Living in an Area Where Malaria is Not Endemic

Contemporary Cesarean Delivery Practice in the United States

A Framework for Human Microbiome Research

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Safety and Immunogenicity of Tetanus Diphtheria and Acellular Pertussis (Tdap) Immunization During Pregnancy in Mothers and Infants: A Randomized Clinical Trial

Efficacy Results of A Trial of A Herpes Simplex Vaccine

Immunologic Features of Infants with Milk or Egg Allergy Enrolled in an Observational Study (Consortium of Food Allergy Research) of Food Allergy

Safety and Immunogenicity of Ebola Virus and Marburg Virus Glycoprotein DNA Vaccines Assessed Separately and Concomitantly in Healthy Ugandan Adults: A Phase 1b, Randomised, Double-Blind, Placebo-Controlled Clinical Trial

Lorazepam vs Diazepam for Pediatric Status Epilepticus: A Randomized Clinical Trial

Central Site Monitoring: Results From a Test of Accuracy in Identifying Trials and Sites Failing Food and Drug Administration Inspection

Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials The Cross Trial Safety Analysis

Complement Factor H Polymorphism in Age-Related Macular Degeneration

Safety and Immunogenicity of DNA Vaccines Encoding Ebolavirus and Marburgvirus Wild-Type Glycoproteins in a Phase I Clinical Trial

Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial

Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo Controlled Multicenter Trial

Chimpanzee Adenovirus Vector Ebola Vaccine - Preliminary Report